GSM Foils Limited
Established in April 2019, GSM Foils Limited specializes in manufacturing Blister Foils and Aluminium Pharma Foils, which are primarily used for packaging pharmaceutical medicines like capsules and tablets.
What GSM files
- Important47
- Others42
- Investor Meet25
- Board Meeting16
- Results9
- PPTs7
GSM Foils reported strong Q1 FY27 performance, with revenue up 86.3% YoY to ₹96.89 Cr and profit after tax (PAT) soaring 98.8% to ₹7.62 Cr. EPS grew from ₹2.99 to ₹5.41. The company specializes in blister and pharma foils for the growing pharmaceutical sector. Growth is driven by strategic capacity...
GSM Foils reported strong Q1 FY27 results. Revenue surged 86.3% YoY to ₹96.89 Cr, driven by robust demand for its pharmaceutical foils. Profit After Tax (PAT) nearly doubled, jumping 98.8% YoY to ₹7.62 Cr, while EBITDA grew 97.7% to ₹11.51 Cr, with margins improving to 11.9%. EPS for the quarter...
GSM Foils delivered strong performance in FY26, with revenue soaring 92.9% YoY to ₹258.15 Cr and profit after tax (PAT) jumping 105.5% to ₹19.84 Cr. Q4 FY26 also saw robust growth, with revenue up 79.1% to ₹81.69 Cr and PAT rising 83.6% to ₹6.28 Cr. EBITDA margin improved slightly to...
GSM Foils, specializing in pharma packaging foils, reported strong Q3 FY26 and 9M FY26 results. Revenue for Q3 surged 84% YoY to ₹66.33 Cr, while 9M revenue doubled to ₹176.47 Cr. Profit after Tax (PAT) for Q3 jumped 96% YoY to ₹5.33 Cr, with 9M PAT rising 118% to ₹13.56...
GSM Foils, a specialist in pharmaceutical foils, delivered a robust performance for H1 FY26. Revenue surged 111.10% YoY to ₹110.14 Cr, while Profit After Tax (PAT) climbed 134.26% YoY to ₹8.23 Cr. EBITDA margin improved to 11.32%. Q2 FY26 also showed strong growth, with revenue up 86.48% YoY to ₹58.14...